Nuarimol

Nuarimol

SCHEMBL29484440

OC(c1ccc(F)cc1)(c1cncnc1)c1ccccc1Cl

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 17/20 0.78
CYP3A4 P08684 2/20 0.58
CYP3A5 P20815 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nuarimol SCHEMBL8818865 1.00 CYP19A1 (0.78) CYP19A1CYP3A4CYP3A5
Nuarimol SCHEMBL20691 1.00 CYP19A1 (0.78) CYP19A1CYP3A4CYP3A5
Fenarimol SCHEMBL4292949 0.96 CYP19A1 (0.86) CYP19A1CYP3A4CYP3A5
Nuarimol SCHEMBL28744100 0.90 CYP19A1 (0.64) CYP19A1CYP3A4CYP3A5
Fenarimol SCHEMBL42209 0.88 CYP19A1 (1.00) CYP19A1CYP3A4CYP3A5
Fenarimol SCHEMBL8360554 0.88 CYP19A1 (1.00) CYP19A1CYP3A4CYP3A5
Fenarimol SCHEMBL6577573 0.88 CYP19A1 (1.00) CYP19A1CYP3A4CYP3A5
Fenarimol SCHEMBL30412723 0.88 CYP19A1 (1.00) CYP19A1CYP3A4CYP3A5
SCHEMBL27282170 0.88 CYP19A1 (0.82) CYP19A1CYP3A4CYP3A5
Fenarimol SCHEMBL8300815 0.87 CYP19A1 (0.97) CYP19A1CYP3A4CYP3A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260117244-A1 INHIBITORY RNA FOR THE CONTROL OF PHYTOPATHOGENS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2026-04-30 US disclosed
US-12595366-B2 Layered collagen materials and methods of making the same MODERN MEADOW, INC. (US) 2026-04-07 US disclosed
EP-4677086-A1 PROTECTION OF PLANTS AGAINST PATHOGENS BY INDUCTION OF SYSTEMIC OR LOCALIZED PROTECTIVE RESPONSES IN PLANTS Greenlight Biosciences, Inc. (US) 2026-01-14 EP disclosed
US-12522825-B2 Control of insect infestation GREENLIGHT BIOSCIENCES, INC. (US) 2026-01-13 US disclosed
EP-3917995-B1 PROTEIN-COATED MATERIALS MODERN MEADOW INC (US) 2024-11-13 EP disclosed
US-20240352457-A1 CONTROL OF INSECT INFESTATION GREENLIGHT BIOSCIENCES, INC. (US) 2024-10-24 US disclosed
WO-2024187037-A1 PROTECTION OF PLANTS AGAINST PATHOGENS BY INDUCTION OF SYSTEMIC OR LOCALIZED PROTECTIVE RESPONSES IN PLANTS GREENLIGHT BIOSCIENCES, INC. (US) 2024-09-12 WO disclosed
US-11932853-B2 Control of insect infestation GREENLIGHT BIOSCIENCES, INC. (US) 2024-03-19 US disclosed
EP-4326874-A1 INHIBITORY RNA FOR THE CONTROL OF PHYTOPATHOGENS The Regents of University of California (US) 2024-02-28 EP disclosed
CN-117098759-A Heterocyclic compounds and their use 组合化学工业株式会社 2023-11-21 CN disclosed
WO-2023112684-A1 LUBRICATING OIL COMPOSITION AND ADDITIVE FOR LUBRICATING OIL ENEOS株式会社 2023-06-22 WO disclosed
CN-115836040-A Formulation system for enhancing composition of nitrogen stabilizer 沃戴申生命科学美国有限责任公司 2023-03-21 CN disclosed
US-11525042-B2 Composite biofabricated material MODERN MEADOW, INC. (US) 2022-12-13 US disclosed
CN-115316397-A Application of bactericidal composition for preventing and treating diaporthe citri 利民化学有限责任公司 2022-11-11 CN disclosed
WO-2022225915-A1 INHIBITORY RNA FOR THE CONTROL OF PHYTOPATHOGENS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-10-27 WO disclosed
US-20220153993-A1 LAYERED COLLAGEN MATERIALS AND METHODS OF MAKING THE SAME MODERN MEADOW INC (US) 2022-05-19 US disclosed
US-20220127784-A1 COLLAGEN-INFUSED COMPOSITE MATERIALS AND METHODS OF MANUFACTURING THE SAME MODERN MEADOW INC (US) 2022-04-28 US disclosed
US-20220106733-A1 PROTEIN-COATED MATERIALS MODERN MEADOW, INC. 2022-04-07 US disclosed
US-11286354-B2 Method for making a biofabricated material containing collagen fibrils MODERN MEADOW, INC. (US) 2022-03-29 US disclosed
US-20220061335-A1 CONTROL OF INSECT INFESTATION GREENLIGHT BIOSCIENCES, INC. (US) 2022-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595366-B2 Layered collagen materials and methods of making the same COL2A1, PLOD3, COL14A1 CYP19A1 3229/4885CYP3A4 3959/4885CYP3A5 3830/4885
US-20260117244-A1 INHIBITORY RNA FOR THE CONTROL OF PHYTOPATHOGENS ATG13, MAVS, ATG7 CYP19A1 2057/4885CYP3A4 2799/4885CYP3A5 3105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.